tiprankstipranks
Konica Minolta Inc (JP:4902)
:4902
Want to see JP:4902 full AI Analyst Report?

Konica Minolta (4902) AI Stock Analysis

3 Followers

Top Page

JP:4902

Konica Minolta

(4902)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
¥528.00
▼(-7.66% Downside)
Action:ReiteratedDate:02/07/26
The score is held back primarily by ongoing losses and earnings volatility, alongside weak technical momentum (below key moving averages with negative MACD and low RSI). Positive operating and free cash flow and moderate, improving leverage provide some support, but valuation remains challenged due to negative earnings and a low dividend yield.
Positive Factors
Strong cash generation
Sustained positive operating and free cash flow provides a durable buffer against earnings volatility, funds organic investment and service/support capability, and reduces near-term refinancing pressure. Over 2–6 months this supports continued investment in software and service attach strategies.
Negative Factors
Loss-making and volatile profitability
Recurring net losses and swings in operating profit undermine long-run capital allocation and reduce retained earnings. Persistent negative margins limit reinvestment capacity, place pressure on management to restructure, and make long-term earnings recovery a material execution risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Sustained positive operating and free cash flow provides a durable buffer against earnings volatility, funds organic investment and service/support capability, and reduces near-term refinancing pressure. Over 2–6 months this supports continued investment in software and service attach strategies.
Read all positive factors

Konica Minolta (4902) vs. iShares MSCI Japan ETF (EWJ)

Konica Minolta Business Overview & Revenue Model

Company Description
Konica Minolta, Inc. engages in digital workplace, professional print, healthcare, and industrial businesses in Japan, the United States, Europe, China, other Asian countries, and internationally. The company develops, manufactures, and sells mult...
How the Company Makes Money
Konica Minolta primarily generates revenue by selling and servicing business-to-business imaging and print infrastructure, complemented by recurring service and software income. Key revenue streams typically include: (1) Office printing: sale or l...

Konica Minolta Financial Statement Overview

Summary
Financial quality is constrained by profitability: revenue is only modestly higher in TTM (+1.9%) but results are volatile and currently loss-making (TTM net margin about -1.2% and negative ROE ~-2.7%). Offsetting this, cash generation is a relative strength with positive TTM operating cash flow (~¥67B) and free cash flow (~¥23B), and leverage is moderate with improving debt-to-equity (~0.89).
Income Statement
38
Negative
Balance Sheet
52
Neutral
Cash Flow
61
Positive
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue1.08T1.13T1.11T1.13T911.43B863.38B
Gross Profit461.77B479.42B475.10B485.94B392.74B374.65B
EBITDA67.73B102.49B102.46B105.03B63.60B62.55B
Net Income-12.65B-47.48B4.52B-103.15B-26.12B-15.21B
Balance Sheet
Total Assets1.22T1.22T1.39T1.41T1.34T1.30T
Cash, Cash Equivalents and Short-Term Investments103.53B89.90B127.13B180.57B117.67B123.82B
Total Debt412.77B438.17B522.58B568.29B448.65B410.70B
Total Liabilities690.64B743.56B834.67B913.90B776.62B749.05B
Stockholders Equity519.65B463.15B539.82B487.42B549.81B539.89B
Cash Flow
Free Cash Flow23.38B25.30B56.08B-8.45B-3.82B52.39B
Operating Cash Flow67.26B51.09B83.34B13.32B37.44B78.06B
Investing Cash Flow26.66B24.65B-76.62B-37.03B-51.00B-37.12B
Financing Cash Flow-101.47B-110.90B-64.77B83.85B2.13B-10.30B

Konica Minolta Technical Analysis

Technical Analysis Sentiment
Positive
Last Price571.80
Price Trends
50DMA
560.46
Positive
100DMA
615.23
Negative
200DMA
561.09
Positive
Market Momentum
MACD
6.47
Negative
RSI
58.53
Neutral
STOCH
74.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4902, the sentiment is Positive. The current price of 571.8 is above the 20-day moving average (MA) of 531.93, above the 50-day MA of 560.46, and above the 200-day MA of 561.09, indicating a bullish trend. The MACD of 6.47 indicates Negative momentum. The RSI at 58.53 is Neutral, neither overbought nor oversold. The STOCH value of 74.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4902.

Konica Minolta Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥790.26B8.327.77%3.16%4.30%78.29%
73
Outperform
¥782.07B18.0410.50%2.03%5.40%23.70%
71
Outperform
¥788.18B8.786.04%2.78%4.46%70.22%
66
Neutral
¥34.61B20.044.37%0.33%-65.09%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
58
Neutral
¥3.79T13.787.81%2.07%5.39%12.69%
47
Neutral
¥294.67B-71.33-12.69%0.71%-11.22%-731.07%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4902
Konica Minolta
596.60
201.39
50.96%
JP:7752
RICOH CO
1,384.50
-26.10
-1.85%
JP:6448
Brother Industries
3,092.00
838.42
37.20%
JP:4901
FUJIFILM Holdings
3,144.00
541.56
20.81%
JP:8060
Canon Marketing Japan Inc.
3,543.00
1,216.52
52.29%
JP:7999
Mutoh Holdings Co., Ltd.
7,590.00
4,947.17
187.19%

Konica Minolta Corporate Events

Konica Minolta Tightens Executive Pay Link to Profit and Shareholder Returns
Mar 26, 2026
Konica Minolta will overhaul its executive compensation framework from fiscal 2026, shifting the pay mix to reduce fixed compensation by 5 percentage points and increase stock-based compensation to 30% for all Executive Officers, including the pre...
Konica Minolta Swings to Profit and Restores Dividend Despite Revenue Decline
Feb 5, 2026
Konica Minolta reported a return to solid profitability for the nine months ended December 31, 2025, despite a 6.1% year-on-year decline in revenue to ¥781.1 billion, reflecting the exclusion of its Precision Medicine Business, now classified...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 07, 2026